Bioengineered Tumor‐Derived Extracellular Vehicles Suppressed Colorectal Cancer Liver Metastasis and Bevacizumab Resistance

Bioengineered Tumor‐Derived Extracellular Vehicles Suppressed Colorectal Cancer Liver Metastasis and Bevacizumab Resistance

Abstract Antiangiogenic therapies, such as bevacizumab, are among the causes of cancer‐related death in patients with colorectal cancer (CRC) with liver metastasis. Delivering siRNAs via primary cell originating from primary cells is a promising method for targeting CRC liver metastasis and drug res...

Full description

Saved in:
Bibliographic Details
Main Authors: Junjiang Wang, Chunsheng Liu, Ping Wang, Zhiyuan Liu, Weixian Hu, Zejian Lv, Chengzhi Huang, Xueqing Yao
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Advanced Science
Subjects:
colorectal cancer
antiangiogenic therapy
engineered extracellular vehicles
liver metastasis
siRNA delivery
Online Access:https://doi.org/10.1002/advs.202417714
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/advs.202417714

Similar Items